Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Function
1. Fenofibrate has significant clinical efficacy in the treatment of lipid abnormalities in diabetic patients.
2. Fenofibrate has the effect of regulating blood lipid.
3. Fenofibrate has anti-inflammatory and lowers fibrinogen levels.
4. Fenofibrate has preventive neuroprotective effects.
Application
Fenofibrate is mainly used for primary hypercholesterolemia or mixed dyslipidemia. Fenofibrate appears to decrease the risk of cardiovascular disease and possibly diabetic retinopathy in those with diabetes mellitus, and firstly indicated for the reduction in the progression of diabetic retinopathy in patients with type 2 diabetes and existing diabetic retinopathy in Australia. It also appears to be helpful in decreasing amputations of the lower legs in this same group of people. Fenofibrate also has an off-label use as an added therapy of high blood uric acid levels in people who have gout.
Tems |
Standards |
Results |
Physical Analysis |
||
Description |
White Powder | Complies |
Assay |
99% | 99.6% |
Mesh Size |
100 % pass 80 mesh | Complies |
Ash |
≤ 5.0% | 2.85% |
Loss on Drying |
≤ 5.0% | 2.65% |
Chemical Analysis |
||
Heavy Metal |
≤ 10.0 mg/kg |
Complies |
Pb |
≤ 2.0 mg/kg |
Complies |
As |
≤ 1.0 mg/kg | Complies |
Hg |
≤ 0.1mg/kg | Complies |
Microbiological Analysis |
||
Residue of Pesticide |
Negative | Negative |
Total Plate Count |
≤ 1000cfu/g | Complies |
Yeast&Mold |
≤ 100cfu/g | Complies |
E.coil |
Negative |
Negative |
Salmonella |
Negative |
Negative |